A phase I study of combined docetaxel and repeated high activity Re-186-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial)

J.M. Van Dodewaard-de Jong, J.M.H. De Klerk, H.J. Bloemendal, B.P.J. Van Bezooijen, M.J. De Haas, Richard Wilson, Joe O'Sullivan

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase I study of combined docetaxel and repeated high activity Re-186-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science